Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
MEDICINE, cilt.89, sa.6, ss.403-425, 2010 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 89 Sayı: 6
- Basım Tarihi: 2010
- Doi Numarası: 10.1097/md.0b013e3181fd8ec3
- Dergi Adı: MEDICINE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.403-425
- İstanbul Üniversitesi Adresli: Hayır
Özet
Autosomal recessive interleukin-1 receptor-associated kinase (IRAK)-4 and myeloid differentiation factor (MyD) 88 deficiencies impair Toll-like receptor (TLR)-and interleukin-1 receptor-mediated immunity. We documented the clinical features and outcome of 48 patients with IRAK-4 deficiency and 12 patients with MyD88 deficiency, from 37 kindreds in 15 countries.